Stinson wins EMD and Merck assignment

Share this article:
Stinson Brand Innovation was awarded a global strategy assignment from EMD Biosciences and Merck Biosciences. Stinson will provide brand alignment and strategic planning services for EMD, a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem, Novabiochem and Novagen.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.